Cleared Traditional

K253814 - Raney Clips Kit

K253814 is the FDA 510(k) clearance for Raney Clips Kit by Beijing Honghugaoxiang Science and Technology Development CO. It is a Class 2 Neurology device (product code HBO) cleared through the Traditional 510(k) pathway after a 235-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2026
Decision
235d
Days
Class 2
Risk

K253814 is an FDA 510(k) clearance for the Raney Clips Kit. Classified as Clip, Scalp (product code HBO), Class II - Special Controls.

Submitted by Beijing Honghugaoxiang Science and Technology Development CO (Beijing, CN). The FDA issued a Cleared decision on July 21, 2026 after a review of 235 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4150 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Beijing Honghugaoxiang Science and Technology Development CO devices

Submission Details

510(k) Number K253814 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 28, 2025
Decision Date July 21, 2026
Days to Decision 235 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
87d slower than avg
Panel avg: 148d · This submission: 235d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HBO Clip, Scalp
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4150
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.